Clinical trial
Use of CyberKnife Radiotherapy for the Treatment of Schwannomas: A Single-Center Retrospective Study
NCT07801560 is registered in ClinicalTrials.gov with Hartmann Oncology Radiotherapy Group, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of CyberKnife Radiotherapy for the Treatment of Schwannomas: A Single-Center Retrospective Study
- Lead sponsor
- Hartmann Oncology Radiotherapy Group, France
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2016
- Completion date
- August 1, 2026
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schwannoma, vestibular